Frank Tufaro, PhD

Frank Tufaro, PhD, has more than 25 years of experience as the founder and CEO of several biotechnology companies. Dr. Tufaro is highly experienced in the development of oncolytic viruses based on herpes simplex and adenovirus.
 
Dr. Tufaro is a former Professor of Microbiology and Immunology at the University of British Columbia and has numerous patent and peer-reviewed scientific publications. He currently serves as a board member and advisor for several biotechnology companies.